![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Medical Solutn | LSE:MLS | London | Ordinary Share | GB0009739649 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 7.72 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Medical Solutions PLC 18 October 2007 For further information, please contact: Medical Solutions plc Nick Ash Managing Director Tel: 0115 973 9010 www.medical-solutions.co.uk Bishopsgate Communications Ltd Nick Rome/Sophie Davis Tel: 0207 5623350 www.bishopsgatecommunications.com 18 October 2007 Medical Solutions plc ('Medical Solutions') Medical Solutions wins LBC agreement in Jersey worth #150,000 The Board of Medical Solutions plc (LSE: MLS), the provider of expert, quality services and products to the healthcare, pharma biotech and life sciences research sectors is pleased to announce that Jersey NHS Trust has chosen the SurePath(TM)liquid based cytology (LBC) system for their cervical screening programme. The Jersey NHS Trust has signed a three year agreement with Medical Solutions for the provision of the SurePath(TM)system worth approximately #150,000 in total. Training with the Trust will commence in November and roll out will be rapid thereafter. Medical Solutions has previously reported the completion of the planned SurePath (TM)LBC system roll out programme in England and Wales, consolidating an estimated 47% of the market share for England and Wales. --ENDS-- About Medical Solutions Medical Solutions is a leading provider of expert, quality services and products to the healthcare, pharma biotech and life science research sectors. Its Healthcare operations provide screening products and reference laboratory diagnostic testing services for cancer and other diseases and additional predictive testing for treatment optimisation for clinicians and patients. Pharma Biotech Services offers support for early stage therapeutic development, offering a "one-stop shop" from tissue pathology, immunohistochemistry, sophisticated image analysis, biomarker determination and assay development to pharmacogenomics including genotyping and gene expression analysis. The Life Science Research services provide core laboratory research support from conceptualization to implementation, calling upon a wide ranging of cutting-edge technology platforms including and an online catalogue of biomolecular tools. This incorporates DNA sequencing, whole genome amplification and a comprehensive library of genomic reagents and clones including cDNA and RNAi. The group has its headquarters in Nottingham, UK where it operates state of the art reference laboratory facilities, with additional UK laboratory facilities in Cambridge and Oxford. Medical Solutions is CPA and GLP accredited and is licensed by the Human Tissue Authority. This information is provided by RNS The company news service from the London Stock Exchange END NRAILFITILLDLID
1 Year Medical Solutions Chart |
1 Month Medical Solutions Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions